Literature DB >> 18821568

Comparison of rehabilitation results in deaf patients with and without genetically related hearing loss.

Maciej Wróbel1, Magdalena Magierska-Krzysztoń, Krzysztof Szyfter, Dorota Mietkiewska, Witold Szyfter, Małgorzata Rydzanicz, Krzysztof Szyfter, Michał Karlik.   

Abstract

The introduction of prognostic tools to evaluate rehabilitation progress in cochlear implant patients (CI patients) is of great importance. The authors attempted to verify whether the identified 35delG mutation in the GJB2 gene can serve as a valuable indicator for rehabilitation progress of CI patients. A group of 51 subjects was studied. Molecular analysis was based on the identification of 35delG in GJB2. Logopedic assessment was performed with a non-verbal test of seven sounds, evaluating detection, discrimination and identification of the sounds during the first, third and sixth months after implantation. Results indicated that patients with GJB2-related deafness (DFNB1)s achieve better results in rehabilitation, but only at the early stages of rehabilitation. Prolonged rehabilitation equalised differences, which, subsequently, excluded this marker as an indicator for rehabilitation evaluation. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821568     DOI: 10.1179/cim.2008.9.3.132

Source DB:  PubMed          Journal:  Cochlear Implants Int        ISSN: 1467-0100


  2 in total

1.  Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis.

Authors:  Robert W Eppsteiner; A Eliot Shearer; Michael S Hildebrand; Adam P Deluca; Haihong Ji; Camille C Dunn; Elizabeth A Black-Ziegelbein; Thomas L Casavant; Terry A Braun; Todd E Scheetz; Steven E Scherer; Marlan R Hansen; Bruce J Gantz; Richard J H Smith
Journal:  Hear Res       Date:  2012-08-28       Impact factor: 3.208

2.  Speech Perception Outcomes after Cochlear Implantation in Children with GJB2/DFNB1 associated Deafness.

Authors:  Marina Davcheva-Chakar; Emilija Sukarova-Stefanovska; Valentina Ivanovska; Vesna Lazarevska; Ilija Filipche; Beti Zafirovska
Journal:  Balkan Med J       Date:  2014-03-01       Impact factor: 2.021

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.